BC Advantage Funds

Allon Therapeutics Inc. (TSX:NPC)is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon's drug davunetide intranasal (AL-108) has demonstrated human efficacy in amnestic mild cognitive impairment, a precursor to Alzheimer's disease. Allon has Phase II human efficacy programs pursuing large underserved markets: Alzheimer's disease, frontotemporal dementia, and schizophrenia-related cognitive impairment. The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC" (Neuro Protection CompanyTM) and based in Vancouver.

Brightside Technologies Inc. was acquired by Dolby Laboratories in May 2007 for USD $28 million, Brightside developed High Dynamic Range image technology for the display of more vibrant pictures and video, primarily on mass-market LCD, front-projection and rear-projection television sets. BC Advantage Funds first invested in Brightside in 2004 and exited with the sale of the Company in 2007 for a 2.8X return multiple.

Aquinox Pharmaceuticals Inc. is a pharmaceutical company committed to the discovery, development, and commercialization of novel and targeted small molecule therapeutics for the treatment of cancer and inflammatory disease. Aquinox's scientific founders discovered a unique biochemical enzyme called SH2-containing inositol 5'-phosphatase (known as SHIP), which can be harnessed in the treatment disorders such as multiple myeloma, leukemia, lymphoma, inflammation, allergy and autoimmune diseases.

Contech Inc. develops, manufactures,and markets innovative, environmentally-friendly products for the commercial forestry, agriculture, and animal husbandry markets, as well as the consumer pet and garden markets.

Contigo Systems Inc. is a leading provider of location-based services using wireless and GPS technology for asset-tracking, fleet management and personal safety applications. Having commercialized a full, web-based solution for employing GPS and mobile solutions to track commercial vehicle fleets, assets and individuals, Contigo’s solutions are distributed under the same name across the U.S. and Canada through a broad network of security companies and GPS resellers.

GaleForce Solutions Inc. is a leading provider of customer relationship management (CRM) software for the financial services industry based on the Microsoft Dynamics platform. GaleForce CRM is an enterprise-class application uniquely suited to the daily workflow of client-facing producers in the financial services industry, including commercial and retail banks, wealth management and capital markets firms.

Inimex Pharmaceuticals Inc. is focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing inflammation. IDR products have major market potential for infectious disease, cancer, and inflammatory disease.

Monexa Technologies Corp. (TSX-V:IPX) provides technologies and services that enable Software Companies and IP service providers to manage product plans, pricing, subscribers and payment over the internet.

MetroBridge Networks International Inc. (TSX-V:MEB) is a leading fixed wireless provider, delivering broadband wireless access to businesses using WiMAX and other advanced wireless technologies. The Company's highly redundant mission critical network provides connections up to 2500Mbps in Canada and the United States.

Mobidia, Inc. provides wireless operators with the ability to better control, manage, and monetize IP data traffic and offer their mobile subscribers innovative and compelling new services.

MSI Methylation Sciences, Inc. is a life science company, focused on reformulating and developing a widely used nutraceutical, with proven safety and efficacy in humans, as a new pharmaceutical for the treatment of depression. MSI is led by an experienced management team including Barry Guld and Nancy Harrison.

Neovasc Inc. (TSX-V:NVC) offers a suite of products to advance the treatment of heart and vascular disease. Neovasc designs technologies to offer improvements to current practice patterns -- in balloon angioplasty, stent insertion and related procedures, and vascular tissue repair.

NxtGen Emission Controls Inc. is an emerging supplier and technology innovator in hydrocarbon fuel processing and is leveraging this technology to support clean diesel, advanced gasoline and alternative fuel engine applications.

Paradigm Environmental Technologies Inc. is the developer of MicroSludge™, a sludge disintegration system that vastly improves the performance of anaerobic digesters for secondary wastewater treatment plants of all sizes.

Parasun Technolgies Inc. was acquired in May 2007 for $12,500,000 by Uniserve Communications. Parasun continues to operate under its name where it provides industry-leading Broadband provisioning and management and support solutions for small and mid-tier network operators. BC Advantage Funds invested in Parasun in 2004 and exited with the sale of the Company for a 4.7X return multiple.

Protox Therapeutics Inc. (TSX:PRX) is at the forefront of developing novel treatments in the emerging field of targeted toxin therapeutics for the treatment of cancer and other proliferative diseases. The company is actively developing two distinct but complementary platforms, INxin(TM) and PORxin(TM), in the development of therapeutic products for its clinical programs.

Recombo Inc. is a leading provider of online agreement and secure electronic signature/digital signature software. Recombo WAYPOINT™ is an online service that lets businesses complete any contract or agreement through email and the internet.

Redlen Technologies manufactures semiconductor compounds (Cadmium Telluride and Cadmium Zinc Telluride), as well as integrated radiation detectors using these compounds. These products are used in a wide variety of industries including nuclear medical imaging, homeland security and thin-film solar.

Sensific Technologies Inc. is a world leader in electro-chemical microsensors and has developed a proprietary electrochemical sensor technology suitable for measuring chemical parameters in solutions.

Sirius Genomics Inc. is a pharmacogenomics and diagnostics company developing DNA-based diagnostic (Dx) and pharmacogenetic (PGx) tests for critical care. Sirius’ product focus is currently concentrated on the development of Dx and PGx tests for sepsis, a systemic blood infection.

Vigil Health Solutions Inc. (TSX-V:VGL) offers a proprietary technology platform combining software and hardware to provide comprehensive solutions to the expanding aged care market. Vigil has established a growing presence in North America and an international reputation for being on the leading edge of systems design and integration.

Voice Mobility International Inc. (TSX:VMY) is a developer and provider of carrier and enterprise enhanced messaging solutions aimed at replacing aging voice mail systems currently deployed and at introducing new enhanced messaging and unified communications capabilities, at a lower total cost of ownership than competitors.

Zeugma Systems Inc. is developing and selling next generation network element designed to optimally deliver voice, video, and data services over a converged broadband network. Zeugma’s product, the Zeugma Service Node (ZSN), delivers the intelligence necessary to optimize quality of service and experience of internet subscribers.